1st Quarter - Report

HARM REDUCTION COALITION for HARM REDUCTION COALITION

Period 1st Quarter 2012 Filed Apr 23, 2012 Signed by WHITNEY ENGLANDER

Official filing
Firm
HARM REDUCTION COALITION
Client
HARM REDUCTION COALITION
Income
—
Expenses
$24,500
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to Naloxone Opioid overdose prevention Viral Hepatitis Testing Act of 2011 Division of Viral Hepatitis Opposition of the reinstatement of the federal funding ban on syringe exchange services

LobbyistCovered position, as disclosed
WHITNEY ENGLANDER —

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.